Celgene slumps as Bristol-Myers shareholder resists merger - Business Insights

Breaking

Post Top Ad

Post Top Ad

Thursday, February 28, 2019

Celgene slumps as Bristol-Myers shareholder resists merger

Shares of Celgene Corp dived 8 percent on Thursday after a major shareholder in Bristol-Myers Squibb Co came out against a $74 billion merger that would be the pharmaceutical world's biggest ever takeover.
Read more at: Source

No comments:

Post a Comment

Post Top Ad